Compartment- and context-specific changes in tissue-type plasminogen activator (tPA) activity following brain injury and pharmacological stimulation

Laboratory Investigation

Volumn 91, Issue 7, 2011, Pages 1079-1091

  Sashindranath, Maithili ^a   Samson, Andre Laval ^a   Downes, Catherine Eliza ^b   Crack, Peter John ^b   Lawrence, Andrew John ^b   Li, Qiao Xin ^b   Ng, Ashley Quan Ping ^b   Jones, Nigel Charles ^b   Farrugia, Jessica Jade ^a   Abdella, Eman ^a   Vassalli, Jean Dominique ^c   Madani, Rime ^c   Medcalf, Robert Lindsay ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

alzheimer's disease; amidolytic assay; head trauma; morphine; seizure; spinocerebellar ataxia; stroke; tissue type plasminogen activator

Indexed keywords

MORPHINE; TISSUE PLASMINOGEN ACTIVATOR;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN DEPTH STIMULATION; BRAIN ISCHEMIA; BRAIN TISSUE; CEREBELLUM; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; IN VIVO STUDY; MALE; MOUSE; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEIZURE; SPINOCEREBELLAR DEGENERATION; SUBCORTEX; TRAUMATIC BRAIN INJURY;

ANIMALS; BASE SEQUENCE; BRAIN INJURIES; BRAIN ISCHEMIA; CELL COMPARTMENTATION; DNA PRIMERS; MICE; MICE, TRANSGENIC; MORPHINE; POLYMERASE CHAIN REACTION; TISSUE PLASMINOGEN ACTIVATOR;

EID: 79959748515     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2011.67     Document Type: Article

References (54)

1. Melchor JP, Strickland S. Tissue plasminogen activator in central nervous system physiology and pathology. Thromb Haemost 2005; 93:655-660. (Pubitemid 40485400)
2. Samson AL, Medcalf RL. Tissue-type plasminogen activator: a multifaceted modulator of neurotransmission and synaptic plasticity. Neuron 2006;50:673-678. (Pubitemid 44218660)
3. Yepes M, Roussel BD, Ali C, et al. Tissue-type plasminogen activator in the ischemic brain: more than a thrombolytic. Trends Neurosci 2009;32:48-55.
4. Granelli-Piperno A, Reich E. A study of proteases and protease-inhibitor complexes in biological fluids. J Exp Med 1978;148:223-234. (Pubitemid 8376490)
5. Shimada H, Mori T, Takada A, et al. Use of chromogenic substrate S- 2251 for determination of plasminogen activator in rat ovaries. Thromb Haemost 1981;46:507-510. (Pubitemid 11049518)
6. Eriksson E, Risberg B. Measurement of tissue plasminogen activator in plasma. A comparison of 3 methods and description of a new improved technique. Thromb Res 1987;46:213-223. (Pubitemid 17069402)
7. Stephens R, Leung KC, Pollanen J, et al. Microplate immunocapture assay for plasminogen activators and their specific inhibitors. J Immunol Methods 1987;105:245-251. (Pubitemid 18015308)
8. Verheijen JH, Mullaart E, Chang GT, et al. A simple, sensitive spectrophotometric assay for extrinsic (tissue-type) plasminogen activator applicable to measurements in plasma. Thromb Haemost 1982;48:266-269. (Pubitemid 13209590)
9. Lu W, Tsirka SE. Partial rescue of neural apoptosis in the Lurcher mutant mouse through elimination of tissue plasminogen activator. Development 2002;129:2043-2050. (Pubitemid 34874218)
10. Li J, Ma Y, Teng YD, et al. Purkinje neuron degeneration in nervous (nr) mutant mice is mediated by a metabolic pathway involving excess tissue plasminogen activator. Proc Natl Acad Sci USA 2006;103: 7847-7852.
11. Madani R, Hulo S, Toni N, et al. Enhanced hippocampal long-term potentiation and learning by increased neuronal expression of tissuetype plasminogen activator in transgenic mice. EMBO J 1999;18: 3007-3012. (Pubitemid 29255609)
12. Carmeliet P, Schoonjans L, Kieckens L, et al. Physiological consequences of loss of plasminogen activator gene function in mice. Nature 1994;368:419-424. (Pubitemid 24115347)
13. Watase K, Weeber EJ, Xu B, et al. A long CAG repeat in the mouse Sca1 locus replicates SCA1 features and reveals the impact of protein solubility on selective neurodegeneration. Neuron 2002;34:905-919. (Pubitemid 34722281)
14. Jankowsky JL, Slunt HH, Ratovitski T, et al. Co-expression of multiple transgenes in mouse CNS: a comparison of strategies. Biomol Eng 2001;17:157-165. (Pubitemid 32409891)
15. Salzberg M, Kumar G, Supit L, et al. Early postnatal stress confers enduring vulnerability to limbic epileptogenesis. Epilepsia 2007;48:2079-2085. (Pubitemid 350098766)
16. Racine RJ. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol 1972;32:281-294.
17. Wong CH, Bozinovski S, Hertzog PJ, et al. Absence of glutathione peroxidase-1 exacerbates cerebral ischemia-reperfusion injury by reducing post-ischemic microvascular perfusion. J Neurochem 2008;107:241-252.
18. Onyszchuk G, Al-Hafez B, He YY, et al. A mouse model of sensorimotor controlled cortical impact: characterization using longitudinal magnetic resonance imaging, behavioral assessments and histology. J Neurosci Methods 2007;160:187-196. (Pubitemid 46241456)
19. Niego B, Horvath A, Coughlin PB, et al. Desmoteplase-mediated plasminogen activation and clot lysis are inhibited by the lysine analogue tranexamic acid. Blood Coagul Fibrinolysis 2008;19: 322-324. (Pubitemid 351670419)
20. Sappino AP, Madani R, Huarte J, et al. Extracellular proteolysis in the adult murine brain. J Clin Invest 1993;92:679-685. (Pubitemid 23262385)
21. Ida N, Hartmann T, Pantel J, et al. Analysis of heterogeneous A4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive Western blot assay. J Biol Chem 1996;271: 22908-22914. (Pubitemid 26304742)
22. Nagai T, Yamada K, Yoshimura M, et al. The tissue plasminogen activator-plasmin system participates in the rewarding effect of morphine by regulating dopamine release. Proc Natl Acad Sci USA 2004;101:3650-3655. (Pubitemid 38338249)
23. Qian Z, Gilbert ME, Colicos MA, et al. Tissue-plasminogen activator is induced as an immediate-early gene during seizure, kindling and longterm potentiation. Nature 1993;361:453-457. (Pubitemid 23050134)
24. Yepes M, Sandkvist M, Coleman TA, et al. Regulation of seizure spreading by neuroserpin and tissue-type plasminogen activator is plasminogen-independent. [see comments.]. J Clin Invest 2002;109:1571-1578. (Pubitemid 34663519)
25. Liu RM, van Groen T, Katre A, et al. Knockout of plasminogen activator inhibitor 1 gene reduces amyloid beta peptide burden in a mouse model of Alzheimer's disease. Neurobiol Aging 2009 (in press).
26. Rogove AD, Lu W, Tsirka SE. Microglial activation and recruitment, but not proliferation, suffice to mediate neurodegeneration. Cell Death Differ 2002;9:801-806.
27. Lu W, Bhasin M, Tsirka SE. Involvement of tissue plasminogen activator in onset and effector phases of experimental allergic encephalomyelitis. J Neurosci 2002;22:10781-10789. (Pubitemid 36005152)
28. Seeds NW, Basham ME, Ferguson JE. Absence of tissue plasminogen activator gene or activity impairs mouse cerebellar motor learning. J Neurosci 2003;23:7368-7375. (Pubitemid 36999527)
29. Thewke DP, Seeds NW. The expression of mRNAs for hepatocyte growth factor/scatter factor, its receptor c-met, and one of its activators tissue-type plasminogen activator show a systematic relationship in the developing and adult cerebral cortex and hippocampus. Brain Res 1999;821:356-367. (Pubitemid 29222799)
30. Lijnen HR, Van Hoef B, Collen D. Influence of cyanogen-bromidedigested fibrinogen on the kinetics of plasminogen activation by urokinase. Eur J Biochem 1984;144:541-544. (Pubitemid 15209348)
31. Muller A, Glattard E, Taleb O, et al. Endogenous morphine in SH-SY5Y cells and the mouse cerebellum. PLoS One 2008;3:e1641.
32. Iyer AM, Zurolo E, Boer K, et al. Tissue plasminogen activator and urokinase plasminogen activator in human epileptogenic pathologies. Neuroscience 2010;167:929-945.
33. Tsirka SE, Gualandris A, Amaral DG, et al. Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator. Nature 1995;377:340-344.
34. Wu YP, Siao CJ, Lu W, et al. The tissue plasminogen activator (tPA)/ plasmin extracellular proteolytic system regulates seizure-induced hippocampal mossy fiber outgrowth through a proteoglycan substrate. J Cell Biol 2000;148:1295-1304.
35. Lahtinen L, Lukasiuk K, Pitkanen A. Increased expression and activity of urokinase-type plasminogen activator during epileptogenesis. Eur J Neurosci 2006;24:1935-1945. (Pubitemid 44583477)
36. Mori T, Wang X, Kline AE, et al. Reduced cortical injury and edema in tissue plasminogen activator knockout mice after brain trauma. NeuroReport 2001;12:4117-4120. (Pubitemid 33152463)
37. Nagai N, De Mol M, Lijnen HR, et al. Role of plasminogen system components in focal cerebral ischemic infarction: a gene targeting and gene transfer study in mice. Circulation 1999;99:2440-2444. (Pubitemid 29218241)
38. Armstead WM, Cines DB, Higazie AA. Plasminogen activators contribute to age-dependent impairment of NMDA cerebrovasodilation after brain injury. Brain Res Dev Brain Res 2005;156:139-146. (Pubitemid 41132123)
39. Dietzmann K, von Bossanyi P, Krause D, et al. Expression of the plasminogen activator system and the inhibitors PAI-1 and PAI-2 in posttraumatic lesions of the CNS and brain injuries following dramatic circulatory arrests: an immunohistochemical study. Pathol Res Pract 2000;196:15-21. (Pubitemid 30046522)
40. Natale JE, Ahmed F, Cernak I, et al. Gene expression profile changes are commonly modulated across models and species after traumatic brain injury. J Neurotrauma 2003;20:907-927. (Pubitemid 37288552)
41. Hamann GF, Burggraf D, Martens HK, et al. Mild to moderate hypothermia prevents microvascular basal lamina antigen loss in experimental focal cerebral ischemia. Stroke 2004;35:764-769. (Pubitemid 38280856)
42. Yepes M, Sandkvist M, Wong MK, et al. Neuroserpin reduces cerebral infarct volume and protects neurons from ischemia-induced apoptosis. Blood 2000;96:569-576. (Pubitemid 30463377)
43. Rosenberg GA, Navratil M, Barone F, et al. Proteolytic cascade enzymes increase in focal cerebral ischemia in rat. J Cereb Blood Flow Metab 1996;16:360-366. (Pubitemid 26125324)
44. Kim JW, Lee SH, Ko HM, et al. Biphasic regulation of tissue plasminogen activator activity in ischemic rat brain and in cultured neural cells: Essential role of astrocyte-derived plasminogen activator inhibitor-1. Neurochem Int 2010.
45. Kingston IB, Castro MJ, Anderson S. In vitro stimulation of tissue-type plasminogen activator by Alzheimer amyloid beta-peptide analogues. Nat Med 1995;1:138-142.
46. Jacobsen JS, Comery TA, Martone RL, et al. Enhanced clearance of Abeta in brain by sustaining the plasmin proteolysis cascade. Proc Natl Acad Sci USA 2008;105:8754-8759. (Pubitemid 351987752)
47. Ledesma MD, Da Silva JS, Crassaerts K, et al. Brain plasmin enhances APP alpha-cleavage and Abeta degradation and is reduced in Alzheimer's disease brains. EMBO Rep 2000;1:530-535.
48. Cacquevel M, Launay S, Castel H, et al. Ageing and amyloid-beta peptide deposition contribute to an impaired brain tissue plasminogen activator activity by different mechanisms. Neurobiol Dis 2007;27:164-173. (Pubitemid 47096796)
49. Fabbro S, Seeds NW. Plasminogen activator activity is inhibited while neuroserpin is up-regulated in the Alzheimer disease brain. J Neurochem 2009;109:303-315.
50. Melchor JP, Pawlak R, Strickland S. The tissue plasminogen activatorplasminogen proteolytic cascade accelerates amyloid-beta (Abeta) degradation and inhibits Abeta-induced neurodegeneration. J Neurosci 2003;23:8867-8871. (Pubitemid 37210899)
51. Roussel BD, Macrez R, Jullienne A, et al. Age and albumin D sitebinding protein control tissue plasminogen activator levels: neurotoxic impact. Brain 2009;132(Part 8):2219-2230.
52. Garcia-Alloza M, Robbins EM, Zhang-Nunes SX, et al. Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease. Neurobiol Dis 2006;24:516-524. (Pubitemid 44716680)
53. Ruan L, Kang Z, Pei G, et al. Amyloid deposition and inflammation in APPswe/PS1dE9 mouse model of Alzheimer's disease. Curr Alzheimer research 2009;6:531-540.
54. Zoghbi HY, Orr HT. Spinocerebellar ataxia type 1. Semin Cell Biol 1995;6:29-35.